News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,105 Results
Type
Article (39173)
Company Profile (283)
Press Release (648649)
Section
Business (203910)
Career Advice (1997)
Deals (35375)
Drug Delivery (89)
Drug Development (80853)
Employer Resources (168)
FDA (16099)
Job Trends (14810)
News (344656)
Policy (32451)
Tag
Academia (2531)
Alliances (49190)
Alzheimer's disease (1262)
Approvals (16061)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11584)
Biotechnology (200)
Breast cancer (190)
Cancer (1377)
Cardiovascular disease (110)
Career advice (1665)
Cell therapy (282)
Clinical research (64712)
Collaboration (485)
Compensation (264)
COVID-19 (2543)
C-suite (109)
Data (1395)
Diabetes (177)
Diagnostics (6170)
Earnings (84895)
Employer resources (146)
Events (110025)
Executive appointments (397)
FDA (16786)
Funding (432)
Gene therapy (195)
GLP-1 (599)
Government (4334)
Healthcare (18697)
Infectious disease (2636)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16348)
Job creations (3625)
Job search strategy (1419)
Layoffs (418)
Legal (7864)
Lung cancer (198)
Manufacturing (207)
Medical device (13215)
Medtech (13220)
Mergers & acquisitions (19198)
Metabolic disorders (461)
Neuroscience (1585)
NextGen Class of 2024 (6501)
Non-profit (4468)
Northern California (1703)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (121)
People (56466)
Phase I (20129)
Phase II (28499)
Phase III (21242)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5892)
Regulatory (21682)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1471)
Startups (3563)
United States (15255)
Vaccines (564)
Weight loss (182)
Date
Today (15)
Last 7 days (413)
Last 30 days (2315)
Last 365 days (35292)
2024 (35164)
2023 (40079)
2022 (51173)
2021 (55710)
2020 (54090)
2019 (46545)
2018 (35025)
2017 (32110)
2016 (31481)
2015 (37554)
2014 (31322)
2013 (26345)
2012 (28577)
2011 (29268)
2010 (27331)
Location
Africa (713)
Arizona (196)
Asia (37285)
Australia (6088)
California (3836)
Canada (1461)
China (309)
Colorado (173)
Connecticut (178)
Europe (79848)
Florida (538)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (635)
Massachusetts (2977)
Michigan (175)
Minnesota (292)
New Jersey (1108)
New York (1094)
North Carolina (743)
Northern California (1703)
Ohio (146)
Pennsylvania (930)
South America (1092)
Southern California (1471)
Texas (555)
Utah (108)
Washington State (401)
688,105 Results for "emulate inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioForest
EMulate Therapeutics Announces the Publication of the Evaluation of Its Ultra-Low Radiofrequency Energy Device in Murine Model of Glioblastoma in BMC Bioelectric Medicine
EMulate Therapeutics, Inc. (EMulate) announces the peer-reviewed publication titled, “Evaluation of the EMulate Therapeutics’ Ultra-Low Radiofrequency Energy (ulRFE®) Device in Murine Model of Glioblastoma (GBM)” in BMC Bioelectronic Medicine.
April 11, 2024
·
5 min read
BioForest
EMulate Therapeutics Inc. Announces Publication of Clinical Results at the SNO 2023 Conference: GBM and DIPG
EMulate Therapeutics, Inc. (EMTx) proudly announced today the acceptance of their abstract for presentation and publication in the 28th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 2023, in Vancouver, British Columbia.
November 14, 2023
·
5 min read
Drug Development
EMulate Therapeutics Announces the Publication of Its Phase I/II Results in CNS Oncology: “An Expanded Safety/Feasibility Study of the EMulate Therapeutics Voyager™ System in Patients with Recurrent Glioblastoma”
EMulate Therapeutics, Inc. (EMulate) announced today the publication of its peer-reviewed clinical trial using EMulate’s technology for the treatment of glioblastoma in the Journal CNS Oncology https://www.futuremedicine.com/doi/10.2217/cns-2022-0016.
July 18, 2023
·
5 min read
Press Releases
Sequential Nested Trial Emulation Presented by Real-World Evidence Leader Target RWE at ISPE 2024
August 21, 2024
·
2 min read
Genetown
Emulate Unveils Chip-A1, Expanding Organ-on-a-Chip Technology Applications Within the Cancer and Cosmetics Markets
Emulate, Inc., the leading provider of next-generation in vitro models, announced the launch of the Emulate Chip-A1™ Accessible Chip through an early access program.
June 26, 2023
·
5 min read
Opinion
Don’t Import Bad Policy Ideas on Drug Pricing
Suggestions that the U.S. should emulate other countries on drug price controls or patents obscure how our present policies have allowed drug development to flourish.
November 13, 2024
·
4 min read
·
Kirsten Axelsen
BioForest
EMulate Therapeutics Inc. (EMTx) Announces Company Presentation at Life Sciences Innovation North-West 2023
EMulate Therapeutics announced that Chris Rivera will present an overview of current results and future plans for EMTx at the Life Science Innovation Northwest 2023.
April 18, 2023
·
5 min read
Business
EMulate Therapeutics Announces the Addition of Donna Morgan Murray, Ph.D., to its Board of Directors
EMulate Therapeutics, Inc. today announced the addition of Donna Morgan Murray, Ph.D. to the Company’s board of directors.
March 14, 2023
·
5 min read
Genetown
Emulate Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
Emulate, Inc., a leading provider of next-generation in vitro models, announced that it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023.
March 2, 2023
·
4 min read
Genetown
Emulate Publishes Landmark Study Validating Organ-on-a-Chip Technology for Predictive Toxicology in Preclinical Development
Emulate, Inc. today announced the publication of a landmark study, “Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology,” in Nature Communications Medicine demonstrating that the Emulate human Liver-Chip could improve patient safety and reduce small-molecule clinical trial failures due to liver toxicity by up to 87%.
December 6, 2022
·
6 min read
1 of 68,811
Next